|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 45/06 | |||
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2822588 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13708156.8 |
| Europos patento paraiškos padavimo data | 2013-03-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/054676 |
| Data | 2013-03-08 |
| (87) | Numeris | WO 2013/132044 |
| Data | 2013-09-12 |
| (30) | Numeris | Data | Šalis |
| 12158519 | 2012-03-08 | EP |
| (72) |
CANNARILE, Michael, DE
RIES, Carola, DE
RUETTINGER, Dominik, DE
WARTHA, Katharina, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF |
| COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF |